Molecule Details
| InChIKey | USAPKSGHDXEZDU-HHHXNRCGSA-N |
|---|---|
| Compound Name | 1-[4-[(2R)-6-bromo-13-chloro-17-methyl-4,15-diazatetracyclo[9.7.0.03,8.014,18]octadeca-1(18),3(8),4,6,11,13,16-heptaen-2-yl]piperidin-1-yl]-2-(1-oxidopyridin-1-ium-4-yl)ethanone |
| Canonical SMILES | Cc1c[nH]c2c(Cl)cc3c(c12)[C@@H](C1CCN(C(=O)Cc2cc[n+]([O-])cc2)CC1)c1ncc(Br)cc1CC3 |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 8.59 |
| Source | ChEMBL;BindingDB;TTD_MultiTarget |
2D Structure
Activity Profile